Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Australia's Immuron gains on highest annual sales for its Travelan drug

** Shares of Immuron IMC.AX rise 11.7% to A$0.067

** Stock set for its strongest session since January 14, if current trend holds

** The biopharmaceutical co says it has exceeded full-year sales of A$5 million ($3.08 million) for its Travelan drug, marking the co's highest annual sales

** About 437,320 shares change hands, 4.2x the 30-day average of 103,595 shares

** Stock down 15.2% YTD, including current session's moves

($1 = 1.6215 Australian dollars)

 (Reporting by Manasi Dasa in Bengaluru)

 ((Manasi.DasaSundeep@thomsonreuters.com;))

Recent news on Immuron

See all news